The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial

Krausz, M; Uhlmann, A; Rump, IC; Ihorst, G; Goldacker, S; Sogkas, G; Posadas-Cantera, S; Schmidt, R; Feisst, M; Alsina, L; Dybedal, I; Recher, M; Warnatz, K; Grimbacher, B

Grimbacher, B (通讯作者)，Albert Ludwigs Univ Freiburg, Fac Med, Ctr Chron Immunodeficiency CCI, Med Ctr,Dept Rheumatol & Clin Immunol, Hugstetter Str 55, D-79106 Freiburg, Germany.;Grimbacher, B (通讯作者)，DZIF German Ctr Infect Res, Satellite Ctr Freiburg, Stuttgart, Germany.

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2022; 30 ():

Abstract

Background: Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) insufficiency and lipopolysaccharide-responsive and beige-like anchor protein (LRBA) ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索